Fulcrum Therapeutics to Attend May Conferences

Fulcrum Therapeutics, Inc.®, headquartered in Cambridge, Massachusetts, has announced its participation in two significant upcoming healthcare conferences. The biopharmaceutical company, listed on Nasdaq under the ticker FULC, is specialized in developing small molecule therapies aimed at improving the lives of patients suffering from genetically defined rare diseases.

On May 15, 2024, Fulcrum’s management will be involved in a fireside chat at the RBC Capital Market Global Healthcare Conference. This event is scheduled for 4:05 p.m. ET. Additionally, on May 20, 2024, the company’s leadership will also participate in the H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ, with their appearance slated for 11:30 a.m. ET. These sessions will provide insights into Fulcrum's current and future projects, and interested parties can register to view the presentations through the provided links.

Fulcrum Therapeutics’ presentations will be accessible via webcast on the "Events and Presentations" section of their website. These presentations will remain available for replay for a minimum of 30 days post-event, offering extended accessibility for those interested in the company’s innovations and progress.

Fulcrum Therapeutics is a company dedicated to addressing high unmet medical needs through the development of small molecule therapies. Their leading programs include losmapimod, a treatment for facioscapulohumeral muscular dystrophy (FSHD), and pociredir, a drug aimed at increasing fetal hemoglobin expression to treat sickle cell disease (SCD) and other hemoglobinopathies. Utilizing proprietary technology, Fulcrum Therapeutics identifies drug targets that modulate gene expression to address the root causes of gene mis-expression, aiming to provide effective treatments for rare genetic conditions.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!